Bangladesh’s pharmaceutical industry could face major challenges after graduation from least developed country (LDC) status due to weak research capacity, reliance on imported raw materials, and the possible loss of patent waivers, which could raise medicine prices, according to experts.

Despite success, Bangladesh's pharma industry hinges on imported raw materials

Govt must help pharma industry navigate LDC graduation challenges

Bangladesh’s pharmaceutical industry is undergoing a significant transformation, driven by young talent and innovation, according to pharmaceutical professionals. 

Pharmaceutical manufacturing hub lying unused even after five years of inauguration